Mod­er­na wraps its BLA for their megablock­buster Covid vac­cine. Chances are you won't have to wait long on the FDA

Two days af­ter Pfiz­er and BioN­Tech land­ed a speedy full ap­proval for their megablock­buster Covid-19 vac­cine, Mod­er­na is step­ping up to the plate at the FDA with their first BLA sub­mis­sion.

Mod­er­na an­nounced Wednes­day that it had com­plet­ed the rolling sub­mis­sion to reg­u­la­tors, boast­ing a 93% ef­fi­ca­cy through six months fol­low­ing the sec­ond jab.

Mod­er­na says it is seek­ing a pri­or­i­ty re­view for the vac­cine, which ear­li­er won an emer­gency OK, but reg­u­la­tors are al­ready primed to blow the doors off this ap­pli­ca­tion — just as they did with the BLA from Pfiz­er/BioN­Tech. The first ap­pli­ca­tion took a grand to­tal of 3 months on which to re­view and stamp an OK, as crit­ics de­mand­ed fast ac­tion and of­fi­cials in the Biden ad­min­is­tra­tion promised a quick re­sponse.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER